Good news and push by wall street on stents.
Tuesday January 27, 8:36 am Eastern Time
Company Press Release
Guidant Announces Market Release of VENTAK MINI III
Defibrillation System in United States
INDIANAPOLIS--(BW HealthWire)--Jan. 27, 1998--Guidant Corporation (NYSE:GDT - news;
PCX:GDT), the worldwide leader in implantable defibrillation systems, today announced the U.S.
market release of the VENTAK(R) MINI(TM) III AICD(TM) Automatic Implantable Cardioverter
Defibrillator system. The VENTAK MINI III is the newest in a series of downsized defibrillators
from Guidant.
Manufactured by Guidant's Cardiac Rhythm Management (CRM) Group, the CPI VENTAK MINI
III is a full featured defibrillation device that includes single-chamber bradycardia pacing therapy. At
only 48 cc in size, the new VENTAK MINI III is designed for patient comfort while maintaining the
full range of sensing, detection, therapy and diagnostic capabilities required for treating patients with
a range of complex life-threatening arrhythmias.
''We created the VENTAK MINI III system to provide customer-focused, time-saving solutions
for the busy clinician,'' noted Jay Graf, president of Guidant's CRM Group. The device's small size,
quick patient follow-up capabilities using Quick Check(TM) and Quick Notes(TM) and flexible
programming options define state-of-the-art convenience in implantable defibrillators.''
The Quick Check and Quick Notes features allow the clinician to easily and quickly perform a
comprehensive series of automatic tests and follow-up device operations, providing a printout that
summarizes the data needed for informed patient management in one concise report. In most cases,
device and patient information stored inside the implantable defibrillator can be retrieved in less than
two minutes, allowing the clinician to focus on other aspects of patient care.
The VENTAK MINI III device is designed for subcutaneous implantation near the patient's
shoulder (pectoral) area. The system incorporates the company's patented ENDOTAK(R) lead and
TRIAD(TM) three-electrode energy defibrillation system. The VENTAK MINI III device can be
programmed with the Model 2901 Programmer/Recorder/Monitor (PRM) for quick, intuitive
programming and follow-up of patients.
A global leader in the medical device industry, Guidant provides innovative, minimally invasive and
cost-effective products and services for the treatment of cardiovascular and vascular disease. For
more information on Guidant's products and services, visit the company's Web site at
guidant.com.
Contact:
Guidant Corporation
Investor Relations: Todd McKinney, 317/971-2094
Media Relations: Carol A. Lindahl, 612/582-4461
Media Relations: Marie Weller, 317/971-2042
More Quotes and News:
Guidant Corp (NYSE:GDT - news)
Related News Categories: biotech, medical/pharmaceutical
|
